Aster Pharmacy gets hard earned accolades for ‘Continuous Improvement’

Dubai/ Delhi: It is not for nothing that Aster Pharmacy has become a household name in UAE. It has emerged as the brand of choice amongst pharmacies due to its improvement on the trot. The Sheikh Khalifa Excellence Award (SKEA) in silver category amply testifies to Aster Pharmacy’s sterling qualities.

Aster Pharmacy did not win this award on a silver platter. There is a long saga of ‘delivering good health and happiness’ through friendly neighbourhood pharmacies. Aster Pharmacy, a division of Aster DM Healthcare, has been honoured for its outstanding performance. Jobilal  Vavachan , CEO, Aster Pharmacy,  received the award from His Highness  Sheikh Hemed bin  Zayed Al Nahyan , chairman of Abu Dhabi Crown Prince’s Court at the award ceremony  held at Emirates Palace Hotel, Abu Dhabi.

Offering the entire gamut of curative , nutritive, baby products, life style, wellness products, FMCG, cosmetics, personal and homecare products,  dots GCC (Gulf Cooperation Council ) healthcare landscape with over 200 pharmacies. It has won hearts and touched millions of lives thanks to its customer first orientation, quality products and services.

The entity followed a prudent growth strategy, demonstrated continuous improvement and achieved excellence through adoption of soundly –based approaches for quality services. Aster Pharmacy, a division of Aster DM Healthcare, is backed by more than two decades of experience in pharmaceutical retailing. Recognized today as the as the region’s leading pharmacy retail chain, Aster Pharmacy started with a focus on ‘delivering good health and happiness’ through friendly neighbourhood pharmacies which were customer centric and easily accessible.

SKEA was launched by the Abu Dhabi Chamber of Commerce and Industry back in 1999 as a blue print, roadmap and methodology for continuous improvement aimed at enhancing the competitiveness of the Business sector in Abu Dhabi and UAE. The SKEA award recognizes organizations that have demonstrated a clear evidence of continuous improvement over their past performance.

  • Related Posts

    Alembic Pharma Gets USFDA Nod for Dapagliflozin

    New Delhi: Alembic Pharmaceuticals Ltd on Tuesday said it has received final approval from the US health regulator for its generic version of dapagliflozin tablets used to control blood sugar…

    Aurobindo Pharma Board approves ₹800 cr share buyback plan

    Generic drugmaker is proposing to buyback more than 54.23 lakh equity shares at ₹1,475 each, fixes April 17, 2026 as the record date Aurobindo Pharma’s Board has approved the generic…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Alembic Pharma Gets USFDA Nod for Dapagliflozin

    Alembic Pharma Gets USFDA Nod for Dapagliflozin

    On World Health Day ‘CAHO Na Patient Se Pyaar Hai’

    On World Health Day ‘CAHO Na Patient Se Pyaar Hai’

    Supreme Court willing to understand Angst of Doctors regarding Consumer Protection Act

    Supreme Court willing to understand Angst of Doctors regarding Consumer Protection Act

    Aurobindo Pharma Board approves ₹800 cr share buyback plan

    Aurobindo Pharma Board approves ₹800 cr share buyback plan

    Three held for cheating SCB Hospital patients on promise of arranging blood

    Three held for cheating SCB Hospital patients on promise of arranging blood

    NATHEALTH resolves to evolve to fit The Bill of Viksit Bharat

    NATHEALTH   resolves to evolve to fit The Bill of Viksit Bharat